I don’t think there’s a point for me to discuss it with my patients”: exploring health care providers’ views and behaviours regarding COVID-19 vaccination

Author:

Dubé Eve12ORCID,Labbé Fabienne1ORCID,Malo Benjamin2ORCID,Manca Terra34ORCID,Aylsworth Laura3,Driedger S. Michelle5ORCID,Graham Janice4ORCID,Greyson Devon6ORCID,MacDonald Noni4,Meyer Samantha B.7ORCID,Parsons Leigh Jeanna8ORCID,Sadarangani Manish910ORCID,Wilson Sarah11ORCID,MacDonald Shannon E.3ORCID

Affiliation:

1. Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Québec, QC, Canada

2. Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Québec, Université Laval, Québec, QC, Canada

3. Faculty of Nursing, University of Alberta, Edmonton, AB, Canada

4. Department of Pediatrics, Dalhousie University, Halifax, NS, Canada

5. Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada

6. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

7. School of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada

8. School of Health Administration, Dalhousie University, Halifax, NS, Canada

9. Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC, Canada

10. Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada

11. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada

Funder

Canadian Immunization Research Network

Canadian Institutes of Health Research

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference59 articles.

1. Government of Canada. (2021). Archived: preliminary guidance on key populations for early COVID-19 immunization [2020-11-03] [accessed 2021 Dec14]. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-key-populations-early-covid-19-immunization.html.

2. World Health Organization. WHO SAGE roadmap for prioritizing uses of COVID-19 Vaccines in the context of limited supply; 2021. [accessed 2022 Jan 11]. https://www.who.int/publications/i/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply.

3. Government of Canada. COVID-19 vaccination in Canada; 2021 [accessed 2022 Jan 14] https://health-infobase.canada.ca/covid-19/vaccination-coverage/.

4. Dionne M, Dubé È, Hamel D, Rochette L, Tessier M Pandémie et vaccination contre la COVID-19 - 21 avril 2022; 2022. [accessed 2022 Apr 27] https://www.inspq.qc.ca/covid-19/sondages-attitudes-comportements-quebecois/vaccination-21-avril-2022.

5. Government of Canada. COVID-19 vaccine uptake and intent: Canadian community health survey (CCHS) insight; 2022 [accessed 2022 Apr 24]. https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/covid-19-vaccine-uptake-intent-canadian-community-health-survey.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3